News
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the American Journal of Ophthalmology has ...
A printable home vision test accurately measured visual acuity in ophthalmology outpatients and displayed high test-retest repeatability in a diagnostic study. “We are excited to be developing a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Infants with type 1 retinopathy of ...
TipRanks on MSN1d
Bausch + Lomb publishes enVista Envy trial results
Bausch + Lomb (BLCO) announced that the American Journal of Ophthalmology has published results of the pivotal U.S. clinical trial of the enVista ...
A new gene therapy can significantly improve the visual acuity of people with Leber hereditary optic neuropathy (LHON), researchers say. LHON often causes legal blindness, but in a compassionate use ...
Field loss may not be the only visual deficit resulting from macular damage while resulting functional losses may impair facial recognition, according to new research published in JAMA Ophthalmology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback